Reuters logo
4 个月前
BRIEF-Agenus commences phase 1 trial with neoantigen cancer vaccine autosynvax
2017年4月5日 / 下午12点59分 / 4 个月前

BRIEF-Agenus commences phase 1 trial with neoantigen cancer vaccine autosynvax

1 分钟阅读

April 5 (Reuters) - Agenus Inc

* Agenus commences phase 1 trial with neoantigen cancer vaccine autosynvax

* Agenus Inc - preclinical data presented at AACR 2017 annual meeting show ASV to be active and synergistic with checkpoint blockade Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below